MedTrace Logo

Mercuri Analysis Contribution on Handicap Evaluation in ArthrogypOsis, a Congenital Neuromuscular Disease

NCT05137756 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2021-11-30

No results posted yet for this study

Summary

The aim is to evaluate the correlation of quantified fibro-adipous infiltration of muscles, using the MRI-based Mercuri score, with deficiencies, activity limitations and social participation in patients with arthrogryposis multiplex congenita.

Conditions

  • Diagnosis of Arthrogryposis Amyoplasia or Distal Arthrogryposis
  • 5 Day Multidisciplinary Evaluation in AMC Clinic of the National Reference Center
  • With Physical Medecin, Medical Genetic and Imaging Departments at the Hospital Grenoble Alpes

Interventions

OTHER

no intervention

no intervention

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Dominic PERENNOU, MDPHD · CHU Grenoble Alpes

  • Klaus DIETERICH, MD · CHU Grenoble Alpes

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2021-07-01
Completion
2021-10-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05137756 on ClinicalTrials.gov